The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Changing Clinical Notes Through Electronic Health Records
As electronic health records become more or less mandatory, the question moves from how widely they are adopted by practices across the country to whether the new versions are more effective than the old pen-and-paper way of doing business.
A 35-Year-Old Man Presents with Non-cardiac Chest Pain and Severe Hypertension
December 8th 2014A 35 year-old man with a history of hypertension, obstructive sleep apnea and obesity presents to clinic with complaints of non-cardiac chest discomfort. He is requesting refills of his blood pressure medications. His insurance changed 6 months ago and he has not had them since. The nurse performs the intake vital signs and reports that the patient has a blood pressure of 280/150 mmHg.
Which Stents Are Better: Drug-Eluting or Bare Metal?
December 5th 2014Cardiologists have discussed the pros and cons of drug-eluting stents (DES) for several years. Some evidence seems to indicate that DES reduce risk of restenosis or ischemia-driven target vessel revascularization. They may, however, be more prone than bare metal stents to late (beyond 1 year) and sudden coronary artery occlusion.
European Society of Cardiology (ESC) Congress 2014
December 3rd 2014The ESC Congress 2014 was one of the largest meetings in the history of the society, with more than 30,300 delegates in attendance at 27 clinical Hot Line presentations; 15 clinical trial updates; 19 registry studies; 4 new guidelines; and 4597 abstracts presented. Cardiology Review profiles 7 presentations.
Amiodarone: Dysrhythmic Drug with Thyroid Effects
December 3rd 2014Clinicians are most likely to prescribe amiodarone when they see patients who have recurrent ventricular dysrhythmias; paroxysmal supraventricular dysrhythmias including atrial fibrillation and flutter; and or need sinus rhythm maintenance after electrical cardioversion for atrial fibrillation.
Zigzag Calorie Cycling: A Novel Path to Weight Loss
December 3rd 2014Also known as alternate day fasting, "zigzag" caloric cycling calls for the dieter to eat the number of calories required to maintain weight one day, and then 25% of his or her energy needs on the fast day. Studies have shown that individuals who are compliant with this pattern can lose 4% to 8% of their body weight over 8 to 12 weeks.
Who Drives 'Innovation in Cardiology
December 3rd 2014This is a time of great change and uncertainty on many fronts in health care, and in cardiology in particular. From new research casting doubts on previously promising procedures (eg, the results from the Symplicity HTN-3 trial released at the 2014 ACC meeting that called into question the usefulness of renal denervation for treating resistant hypertension) to the continued chaos and turmoil surrounding the implementation and future of the Affordable Care Act (ACA), it seems the news raises more questions than it answers.
Warfarin for Atrial Fibrillation?
A recent study published in the Journal of the American Medical Association looked at whether the prescription, which also required the patient continuously monitor their coagulation, was the best option. The study focused on whether mechanical left atrial appendage would be preferable for patients going forward.
Age-related Diseases Don't Occur Earlier in HIV-infected Patients
December 1st 2014Despite previous research suggesting HIV patients have an increased likelihood of suffering from a heart attack, kidney failure, or cancer, Johns Hopkins Bloomberg School of Public Health investigators showed the age they encounter these conditions were similar to their uninfected counterparts.
Can We Preserve Cognitive Function in Patients with Atrial Fibrillation?
Despite much evidence that atrial fibrillation (AF) greatly increases the risk of cognitive decline, a review of research to date finds little compelling support for any particular strategies to minimize that risk.
Vascular Disease and its Link to Erectile Dysfunction
Men of all ages are experiencing the difficulties that come with cardiovascular health including erectile dysfunction. A recent study was conducted looking at the link between the two conditions and what can be done to improve their treatment.
Correcting Short Stature: Long-Term Risks May Include Stroke
November 23rd 2014Early reports from the Safety and Appropriateness of Growth hormone treatments in Europe (SAGhE) project noted increased cardiac and cerebrovascular mortality in adults who were treated for stature problems as children. In addition, other studies have linked stroke risk to short stature in general, hypothesizing that shorter people have increased metabolic risks.